Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05524298 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 9 months later Feb 2026 → Dec 2026
See other at-risk trials from Fondazione Italiana Linfomi - ETS

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Feb 2026 to Dec 2026
    • Study sites: 20 to 21
    v12
  2. Study sites: 19 to 20v11
  3. Site details revised at 2 of 19 sitesv10
  4. Primary and study completion dates: Feb 2025 to Feb 2026
    • Site contacts updated at 19 of 19 sites
    v9
  5. Site details revised at 19 of 19 sitesv8
Show 6 earlier versionsHide 6 earlier versions
  1. Site details revised at 3 of 19 sitesv7
  2. Site details revised at 6 of 19 sitesv6
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Dec 2022 to Dec 7, 2022
    • Site details revised at 19 of 19 sites
    v5
  4. Start date: Nov 2022 to Dec 2022v4
  5. Start date: Sep 2022 to Nov 2022
    • Primary endpoints revised (6)
    v3
  6. Start date: Aug 2022 to Sep 2022v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Aims of this study are to describe the variation of QoL (Quality of Life) during the clinical management of low-grade lymphoma in elderly subjects and to identify the most important factors at diagnosis and during treatment with an impact on QoL (Quality of Life).
Trial Details
NCT Number NCT05524298
Lead Sponsor Fondazione Italiana Linfomi - ETS
Conditions
(from sponsor)		 Low Grade Non-Hodgkin's Lymphoma, Adult
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov